Cargando…

Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: A case report

RATIONALE: Occult breast cancer (OBC) is a rare type of breast cancer without any symptoms in the breast and is often presented with initial symptoms of axillary lymph node metastasis or other metastases. The low incidence rates of OBC make it a great challenge to diagnose and cure. PATIENT CONCERNS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lulu, Zhang, Jingjing, Chen, Mingtai, Ren, Saisai, Liu, Haihui, Zhang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690751/ https://www.ncbi.nlm.nih.gov/pubmed/29137058 http://dx.doi.org/10.1097/MD.0000000000008529

Ejemplares similares

Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
por: Xu, Ruixin, et al.
Publicado: (2017)

Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports
por: Yang, Haisong, et al.
Publicado: (2017)

PPAR Gamma-Regulated MicroRNA 199a-5p Underlies Bone Marrow Adiposity in Aplastic Anemia
por: Zhang, Xianning, et al.
Publicado: (2019)

Ovarian cancer metastasis to the breast 18 years after the initial diagnosis: A case report
por: Wang, Zinan, et al.
Publicado: (2019)

Clinicopathologic features of single bone metastasis in breast cancer
por: Karatas, Murat, et al.
Publicado: (2021)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

Antrodia cinnamomea is a potentially effective complementary medicine for adjuvant therapy against breast cancer with bone metastasis: A case report
por: Long, Huei, et al.
Publicado: (2020)

CalliSpheres drug-eluting beads transarterial-chemoembolization in the treatment of liver metastases from breast cancer: Initial experience in 14 patients
por: Chang, Xu, et al.
Publicado: (2021)

Screening and identification of hub-gene associated with brain metastasis in breast cancer
por: Li, Xiao-Gang, et al.
Publicado: (2023)

Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer
por: Chen, Yujuan, et al.
Publicado: (2017)

Breast liposarcoma with solitary metastasis to the pleura: A case report
por: Lei, Lei, et al.
Publicado: (2017)

Brain metastasis with subtype conversion in a patient with male breast cancer: A case report
por: Oh, Byeong Ho, et al.
Publicado: (2021)

Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
por: Al-Muqbel, Kusai M., et al.
Publicado: (2016)

Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment
por: Ren, Xiaofei, et al.
Publicado: (2023)

Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer
por: Lim, Chae Hong, et al.
Publicado: (2016)

Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review
por: Xiong, Jie, et al.
Publicado: (2017)

Gastric metastasis from invasive lobular breast cancer, mimicking primary gastric cancer: A case report
por: Kim, Dae Hoon, et al.
Publicado: (2018)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

Effectiveness of intervention for aromatase inhibitor-associated musculoskeletal symptoms: A protocol for systematic review and meta-analysis
por: Meng, Hui, et al.
Publicado: (2022)

Volume-based metabolic parameter of breast cancer on preoperative (18)F-FDG PET/CT could predict axillary lymph node metastasis
por: An, Young-Sil, et al.
Publicado: (2017)

Primary tumor resection for initially staged IV breast cancer: An emphasis on programmed death-ligand 1 expression, promoter methylation status, and survival
por: Erol, Timuçin, et al.
Publicado: (2019)

In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study
por: Zhang, Lingyun, et al.
Publicado: (2021)

Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study
por: Hou, Niuniu, et al.
Publicado: (2021)

Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma
por: Zheng, Lihua, et al.
Publicado: (2020)

Pilonidal sinus involving the breast in a man: A case report and literature review
por: Shi, Rong, et al.
Publicado: (2021)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
por: Jiang, Di, et al.
Publicado: (2023)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
por: Liu, Shuyu, et al.
Publicado: (2020)

Chidamide suppresses adipogenic differentiation of bone marrow derived mesenchymal stem cells via increasing REEP2 expression
por: Zhang, Xianning, et al.
Publicado: (2023)

The Associations of Single Nucleotide Polymorphisms in miR196a2, miR-499, and miR-608 With Breast Cancer Susceptibility: A STROBE-Compliant Observational Study
por: Dai, Zhi-Ming, et al.
Publicado: (2016)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Association between miR-27a rs895819 polymorphism and breast cancer susceptibility: Evidence based on 6118 cases and 7042 controls
por: Liu, Yuan, et al.
Publicado: (2021)

Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients
por: Zhang, Xinyue, et al.
Publicado: (2022)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
por: Li, Jingping, et al.
Publicado: (2021)

Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis
por: Liu, Linlin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6nr2oe04kb6q9iug9uv4v3km8